Therapeutic potential of nitric oxide in vascular aging due to the promotion of angiogenesis

被引:6
|
作者
Zhang, Jiaming [1 ]
Li, Cunrui [1 ]
Zhang, Yihua [1 ]
Wu, Jianbing [1 ]
Huang, Zhangjian [1 ,2 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Discovery, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Peoples R China
[2] Xinjiang Med Univ, Sch Pharm, Urumqi, Peoples R China
基金
中国国家自然科学基金;
关键词
angiogenesis; endothelial cells; nitric oxide; senescence; vascular aging; ENDOTHELIAL PROGENITOR CELLS; SOLUBLE GUANYLYL CYCLASE; OXIDATIVE STRESS; GROWTH-FACTOR; CELLULAR SENESCENCE; VEGF EXPRESSION; DOWN-REGULATION; L-ARGININE; SYNTHASE; ENOS;
D O I
10.1111/cbdd.14248
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The decrease in angiogenesis that occurs with aging significantly contributes to the higher incidence and mortality of cardiovascular diseases among the elderly. This decline in angiogenesis becomes more pronounced with increasing age and is closely linked to abnormal function and senescence of endothelial cells. Enhancing angiogenesis in aging and targeting senescent endothelial cells have gained considerable attention. Nitric oxide (NO) has been thoroughly investigated for its function in regulating angiogenesis and is an important factor that can counteract endothelial cell senescence. This review summarizes the mechanisms of reduced angiogenesis during aging and therapeutic strategies targeting senescent cells. We also discuss the potential of combining the current approaches with NO in promoting angiogenesis in aging vessels.
引用
收藏
页码:395 / 407
页数:13
相关论文
共 50 条
  • [21] Inhibition of nitric oxide synthase as a potential therapeutic target
    Hobbs, AJ
    Higgs, A
    Moncada, S
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 191 - 220
  • [22] THERAPEUTIC POTENTIAL OF NITRIC OXIDE MODULATION IN OCULAR DISEASES
    Drago, Filippo
    Bucolo, Claudio
    DRUG NEWS & PERSPECTIVES, 2010, 23 (07) : 430 - 437
  • [23] Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging
    Bach, MHM
    Sadoun, E
    Reed, MJ
    MECHANISMS OF AGEING AND DEVELOPMENT, 2005, 126 (04) : 467 - 473
  • [24] Nitric oxide synthase inhibitors with cardiovascular therapeutic potential
    Hansen, DW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (05) : 537 - 547
  • [25] Therapeutic potential of nitric oxide synthase gene manipulation
    von der Leyen, HE
    Dzau, VJ
    CIRCULATION, 2001, 103 (22) : 2760 - 2765
  • [26] The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches
    Zhu, Han-Yan
    Hong, Fen-Fang
    Yang, Shu-Long
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [27] Angiogenesis, Cancer, and vascular Aging
    Moriya, Junji
    Minamino, Tohru
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2017, 4
  • [28] Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis
    Kimura, H
    Esumi, H
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 49 - 59
  • [29] Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?
    Kapila, V
    Sellke, FW
    Suuronen, EJ
    Mesana, TG
    Ruel, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (01) : 37 - 44
  • [30] The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling
    Farsetti, Antonella
    Grasselli, Annalisa
    Bacchetti, Silvia
    Gaetano, Carlo
    Capogrossi, Maurizio C.
    JOURNAL OF APPLIED PHYSIOLOGY, 2009, 106 (01) : 333 - 337